Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Rapid Diagnostic Test Kits Market $35.6 Billion by 2027

The global market for rapid diagnostic test kits to reach nearly $35.6 billion by 2027, growing at a CAGR of 4.9% over the forecast period, driven by quick and easy, preliminary and emergency medical screening technological advancements in the field worldwide.

  • Other factors driving market growth include rising incidence of diabetes, inflammatory and infectious diseases, growing elderly population, high unmet medical needs, rising prevalence of chronic and infectious diseases, and drug abuse cases, and rapid adoption of rapid diagnostic kits, globally.
Global Rapid Medical Diagnostic Kits Market

Rapid diagnostic tests (RDTs) are increasingly used for identification of antigen and are required for treatment of symptomatic patients.

  • RDTs are low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time.
    • RDT can be utilized in faster identification of causative pathogens, reducing time to appropriate antimicrobial therapy, minimizing antibiotic resistance, decreasing costs associated to inappropriate antibiotic use and improving patient outcomes.
      • Therefore, procurement of RDT may increase expense for the microbiology laboratory, but the cost savings can be derived by reducing unnecessary diagnostic tests, pharmacy drug costs from reducing inappropriate antibiotic therapy, infection control savings for decreased infections due to reductions in transmission of organisms and reduced length of hospital stay. 
  • For rapid diagnosis of bacterial meningitis, immunochromatography or latex agglutination tests have been the techniques most commonly used.

Some of the examples of rapid diagnostic tests include:

  • RDT for malaria to reduce unnecessary use of antimalarials could drive up untargeted use of antibiotics.
  • The PNA-FISH (Peptide Nucleic Acid Fluorescent In Situ Hybridization Molecular Strains) allow the visualization of target microorganism. 
  • The real-time polymerase chain reaction (rPCR) technology is built into the GeneXpert system, allows automation and integration of sample preparation, nucleic acid amplification and detection of target sequence. 
  • The MALDI-TOF is an innovative mass spectroscopy technology to identify microorganisms. 
  • The nucleic acid microarray assay allows identification of pathogens and resistance markers. 
  • RDTs may improve the early detection of visceral leishmaniasis (VL) and sexually transmitted infections (STIs).

The rapid medical diagnostic testing kits market report estimates the market size ($million 2017 to 2027), market share, growth trends and forecast (CAGR% 2021 to 2027).

The global market for rapid diagnostic test kits segmented by product / technology [flow-through assays, lateral flow immunoassays (immunochromatographic strip tests), latex agglutination assays, solid-phase assays (dipstick assays)], medical application [hospital testing, clinical testing, home-based testing, and veterinary testing (blood glucose testing, infectious disease testing, cholesterol monitoring, fertility and pregnancy testing, substance of abuse testing, and veterinary testing)], and geography.

  • Based on the products or test or technology, the lateral flow immunoassays segment accounted for the largest share of the total RDT market.
    • The lateral flow diagnostic technology has been widely used for home testing, laboratory testing and point of care testing.
      • The advantages of lateral flow tests include ease of operation, rapid diagnostic procedure, storage at room temperature, visual inspection of results, lesser chances of error and easy availability in the market.
    • However, the solid-phase testing kits, also known as dipstick assays or dipstick comb assays segment predicted to witness fastest growth rate during the forecast period. due to ease of use, rapid delivery of test results, small sample requirements, and multiple parameter testing in the same assay.
  • In terms of medical applications, the home-use market for RDT kits segment held majority of the market, owing to rapidly growing home healthcare market and increasing patient awareness.
    • However, the clinical testing applications segment anticipated to register fastest growth rate in the coming years, owing to utilization of RDT kits in a wide range of healthcare settings such as hospitals, clinics, clinical laboratories, rapid clinics and other healthcare facilities, including emergency and ambulatory services.
    • The infectious diseases testing market for RDT kits segment dominated the total market, owing to the increasing demand in the clinical settings for quick diagnosis, high unmet needs and patient turnaround time.
      • However, its market share expected to decline marginally due to rapid increase in the cholesterol and substance abuse testing market during the forecast period.

The global RDT market research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

  • Geographically, the North America region dominated the total market, followed by the Europe region, due to increasing patients’ awareness and presence of a large number of FDA approved products and pre-qualified laboratories in these regions.
    • However, the Asia Pacific RDT kits market forecast to register the fastest CAGR over the next few years, attributed to rising incidence of diabetes, inflammatory and infectious diseases, growing elderly population, high unmet medical needs, rising prevalence of chronic and infectious diseases, and drug abuse cases, and rapid adoption of rapid diagnostics for a wide range of infectious disease in the emerging countries.

The global market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for rapid medical diagnostic kits and included in this report are Abbott Laboratories, Abaxis, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, MegaCor Diagnostik GmbH, Roche Holding AG (F. Hoffmann La Roche AG), Trinity Biotech, and Zoetis, Inc.

  • Product / Test / Technology
    • Flow-through Assays
    • Lateral Flow Immunoassays {Immunochromatographic Strip Tests)
    • Latex agglutination Assays
    • Solid-Phase Assays (Dipstick)
  • Application
    • Hospital Testing
      • Blood Glucose Testing
      •  Cholesterol Monitoring
      • Fertility & Pregnancy Testing
      • Infectious Disease Testing
      • Substance Abuse Testing
    • Clinical Testing
      • Blood Glucose Testing
      • Cholesterol Monitoring
      • Fertility & Pregnancy Testing
      • Infectious Disease Testing
      • Substance Abuse Testing
    • Home Based Testing
      • Blood Glucose Testing
      • Cholesterol Monitoring
      • Fertility & Pregnancy Testing
      • Infectious Disease Testing
      • Substance Abuse Testing
    • Veterinary Testing
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
      Rest of the World
  • Company Profiles
    • Abaxis, Inc.
    • Abbott Laboratories, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation (Beckman Coulter)
    • MegaCor Diagnostik GmbH
    • Roche Holding AG (F. Hoffmann La Roche AG)
    • Trinity Biotech plc
    • Zoetis, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/rapid-medical-diagnostic-kits-market/

Related publications:



    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]